Such a wonderful medicine of high therapeutic value which saves people from worst heart ailments is not always suggested by the physicians without rendering a thorough check up of the patient. Even after suggesting the digitek medication starting with minimal dosage levels the patient is kept under strict surveillance by the physicians to observe and study the acquaintance level of the patient’s body with the digitek dosage. When everything is found to be quite normal without any form of mental or physical side effects shown by the patient then the dosage is slightly increased in sequential steps to optimum levels needed for curing the cardiac ailment of the patient completely.The patients are strictly warned of their regularity in the timings of their dosages and emphasized emphatically to report on missing any particular dose and not to combined two doses at one time at any case, never ever. This much intensive care is taken in the utilization of the drug because of the obvious reason that its contents are nothing but from fox glove. Yes, the digitalis content in the digitek in micro ounces of quantity if by mistake is added in excess a bit at micro levels would lead to lethal effects in the patient.

When the above illustrated information is quite enough for anyone to understand the utmost importance of the dosage levels of the drug digitek, Actavis, the manufacturers of the drug digitek, the very profound pharmaceutical firm with experts and scientists in their research team and operation should not have shown any negligence in the dosage part of the drug. But when they do so and that too after being alerted by the FDA twice then there cannot be any excuse given to them for their grave mistake. They would neither justify their mistake nor be forgotten just because they have recalled all the medicines after a long time. They will have to answer for their social and moral irresponsibility of pinnacle heights. The disastrous situation of the affected innocent victims and their affectionate family’s financial unstable situation because of the losses incurred due to the ailment should all be brought into the light of the jury with details. Digitek lawsuits have to be filed against them massively by many communities across the United States. Proper compensation should be given to the affected victims to pacify them at least to a certain extent monetarily. So as to approach concerned lawyers specialized in digitek lawsuits from quite long time now.

Digitalis poisoning is an erroneous digitalis treatment as well as it might be the result of excessive doses of the drug digitek which uses Digitalis. Digoxin drugs have been recalled absolutely by Caraco as there is potential level of danger involved in its intake to the patients. Watson also has recalled all Propafenone for anticipated troubles. When compared to them the belated action of Actavis, misinterpreting Digitek as good to use can be sued. Patients or their kith and kin must provide detailed report of their medical records so far without hiding anything to the digitek lawyers to sue against the manufacturers of Digitek.

All the medical shops are given strict instructions by the FDA to scrutinize the buyers list to find out who all have bought digitek and make them aware of the erroneous dosage of medicines supplied by the companies and advise them the curtail the usage anymore. Educating them about the prospective dangerous results one might acquire by prolonged continuous usage of the drug anymore is very vital. All those who had taken the drug in the recent couple of years have been asked to consult their doctors immediately to avoid any problems in the future. Also people can contact their nearest pharmacies in helping them out in taking back the digitek drugs whatever they have purchased already intending to preserve in stock.

Therapeutics are the major area where ultimate care has to be taken in using digoxin because in this area if digoxin doses go excess may result to serious drawbacks of blockages in the heart.

The heart blocks caused may be of various levels depending upon the dosage level and so are the worse effects caused by them too.

Digoxin causes skin irritation and rash too.

Digoxin can cause you bad side effects related to sight, unclear vision and pale yellowish eyes, etc.,

Digoxin can generate serious intermittent pain in your forehead, the person can become very weak and might feel giddy very often, anxiety levels are hiked, and the affected person is totally baffled out mental state of mind and would end up resulting in frightening dreams.

Gynecomastia is the found to be caused as a result of using digoxin for continuous period of time.

The side effects of digoxin in the kids are extremely varying when in comparison to the adults. Cardiac arrhythmias and so many other arrhythmias are said to be the first symptom, mostly observed and confirmed with many of the children affected due to over dosage of the drug.

Furthermore, kids throw up very often, nausea, dysentery is also seen more frequently as major side effects of the excessive dosage.

The production imperfection resulted in the inferior quality products of digitek digoxin toxicity have adversely affected to its worst part.

It has been proven a tablet of digitek digoxin contains more than 200 percent of the actually required amount of contents to be present in it. The walls of the capsules were found with an abnormal thickness from the regular standards to be used. This is when done with double dosage contents inside may lead to lethal effects in the consumer apart from the ordinary drawbacks what it can create on an individual.

Even though actavis, the manufacturer as well as the government has taken necessary steps to try fixing the issue,. It is the social responsibility of each an everyone to pass on this awareness to as many as possible so that no community will be inflicted any further because of ignorance.

Heart patients in the US who were getting treated for heart failure and abnormal heart rhythms complained of nausea, vomiting, dizziness, low blood pressure, cardiac instability, and bradycardia and in some other cases even death was reported. It was further found out that the symptoms were more prevalent in those patients who were administered a drug called Digoxin which was being marketed under the registered trademark of Digitek owned by Actavis Totowa(formerly Amide Pharmaceutical, Inc.).This drug is distributed by Mylan Pharmaceuticals Inc., under a Bertek label and by UDL Laboratories, Inc. under a 'UDL' label.
Digitek starts working by taking a direct action on our cardiac muscle, in addition to this it also takes an indirect action on the cardiovascular system and the autonomic nervous system of our body.

The autonomic effects include: (1) a vagomimetic action, which is responsible for the effects of Digitek (Digoxin) on the sinoatrial and atrioventricular (AV) nodes; and (2) baroreceptor sensitization, which results in increased afferent inhibitory activity and reduced activity of the sympathetic nervous system and renin-angiotensin system for any given increment in the mean arterial pressure.

The pharmacologic consequences of these direct and indirect effects are: (1) an increase in the force and velocity of myocardial systolic contraction (positive inotropic action); (2) a decrease in the degree of activation of the sympathetic nervous system and renin-angiotensin system (neurohormonal deactivating effect); and (3) slowing of the heart rate and decreased conduction velocity through the AV node (vagomimetic effect).

The effects of Digitek (Digoxin) in heart failure are mediated by its positive inotropic and neurohormonal deactivating effects, whereas the effects of the drug in atrial arrhythmias are related to its vagomimetic actions. In high doses, Digitek (Digoxin) increases sympathetic outflow from the central nervous system (CNS). This increase in sympathetic activity may be an important factor in Digitek (digitalis) toxicity.

Digitek (Digoxin) is available in tablet, capsule, liquid, and injectable forms, however the Digitek recall relates only to the tablets. It has been found that these tablets contain twice the approved/recommended dosage of the medicine. Also the medical providers have ascertained that if these tablets are ingested, it can result in severe medical complications caused by digitalis toxicity, which is a medical condition which leads to very serious side effects which are nausea, vomiting, dizziness, low blood pressure, cardiac instability and even death.
The condition of Digitek Digoxin toxicity is found to be associated with a manufacturing defect from Digitek. It has also been found that the tablets may contain twice the approved or recommended levels of dosage. The tablets were also found with double the thickness which is appropriate for commercial release, making it a double-strength pill which led directly to a risk of Digitek toxicity which causes nausea, vomiting, low blood pressure, cardiac instability, bradycardia and even death.

To put is simply “Digitek (Digoxin) inhibits sodium-potassium ATPase, an enzyme that regulates the quantity of sodium and potassium inside the cells. Inhibition of the enzyme leads to an increase in the intracellular concentration of sodium and thus (by stimulation of sodium-calcium exchange) an increase in the intracellular concentration of calcium.”

These Digitek tablets are prescribed to those patients who suffer serious heart problems, such as, irregular heartbeat, arterial fibrillation, and congestive heart failure. It is available in tablet, capsule, liquid, and injectable forms, however the Digitek recall relates only to the tablets.

de FDA had already given a warning to Actavis informing them about the danger which their medicine was posing for the patients who were administered with these pills, however despite reports of health issues in the consumers of Digitek, Actavis failed to provide them the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.
There were also some out-of-specification (OSS) test results that were not documented properly and the product was released based on retesting without providing any valid reasons for ignoring the initial OSS results.

In response to the FDA’s warning letter, Actavis responded by promising to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it was too late and Actavis should have been more efficient around the recall and taking prompt actions.
Pharmacies across the US have been informed about this medicine and advised them to call up the people who have purchased this medicine and inform them about the harmful side effects of this medicine.

The manufacturers have recalled Digitek. Actavis Totowa (formerly Amide Pharmaceutical, Inc.), post findings that some of the tablets contained twice the approved level of the active ingredient used in the medicine immediately recalled its product from the shelves. The class I recall was initiated in April 2008 when the FDA started receiving reports of severe illnesses amongst patients who were administered a drub called Digitek. These tablets were a double-strength tablets that caused toxicity in the patients suffering from renal failure. These tablets caused a condition called Digitalis, which accumulated in the body instead of being passed out through urine. This dysfunction disrupts the proper functioning of the kidney and further aggravates the toxicity leading to problems, such as, nausea, vomiting, diarrhea, dizziness, low blood pressure, cardiac instability and bradycardia.

Digitek is another form of digitalis; it comes from a chemical derived from the ‘foxglove plant’. This has been used as a heart medicine since the 18th Century. The FDA (Food & Drug Administration) sited the recall as a Class I recall as the defective Digitek drug could cause potentially serious health problems or death. Few other symptoms of Digitalis toxicity include nausea, vomiting, diarrhea, dizziness, confusion, loss of appetite, low blood pressure, cardiac instability and irregular pulse, weakness, confusion, hallucinations, and heart palpitations. Some patients suffering from Digitalis or Digoxin toxicity may suffer from yellow vision in which objects and light appear yellow in color and blurred. Digoxin / Digitalis toxicity may also result in low heart rate called bradycardia and in increased or rapid heartbeat called tachycardia. Digitalis / Digoxin/ Digitoxin toxicity may cause severe weight loss due to the reduced appetite.

Despite reports of health issues in the consumers of Digitek, Actavis has did not take appropriate or necessary steps to provide the FDA with the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for being negligent, irresponsible and for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.

The report further mentions that the out-of-specification (OSS) test results were not documented properly and the product was released based on retesting without providing any valid reasons for ignoring the initial OSS results.

Actavis responded to the FDA and promised to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it is compliant with the good manufacturing practices.
As part of a Class I recall, all pharmacies are doing a double check on the list of their patients who have been prescribed this medicine and they are even calling up the patients informing them about the faulty medicines.

For more information about the Digitek Recall see Digitek Recall.

Actavis responded to the FDA and promised to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it is compliant with the good manufacturing practices.
As part of a Class I recall, all pharmacies are doing a double check on the list of their patients who have been prescribed this medicine and they are even calling up the patients informing them about the faulty medicines.

Digitek has been voluntarily recalled by its manufacturer, Actavis Totowa (formerly Amide Pharmaceutical, Inc.), after it was suspected that some of the tablets may contain twice the approved level of the active ingredient used in the medicine. The class I recall happened in April 2008 when the FDA had received the reports of severe illnesses amongst patients using Digitek. These double-strength tablets may cause toxicity in the patients suffering from renal failure, which causes digitalis to accumulate in the body instead of being passed out through urine. This disrupts the proper functioning of the kidney and further aggravates the toxicity leading to problems, such as, nausea, vomiting, diarrhoea, dizziness, low blood pressure, cardiac instability and bradycardia.

What is Digitek?
Digitek tablets are prescribed to those patients who suffer serious heart problems, such as, irregular heartbeat, arterial fibrillation, and congestive heart failure. It is available in tablet, capsule, liquid, and injectable forms, however the Digitek recall relates only to the tablets.

How did it happen?
Despite reports of health issues in the consumers of Digitek, Actavis has failed to provide them the information on how long and how many of these double-dosed pills have been in circulation. Many consumers have already filed lawsuit against Actavis for not warning the patients about the risks of consuming Digitek. It has also not been able to explain the reasons for such manufacturing faults. It is interesting to know that Actavis had received warnings from the FDA in 2006 and 2007 as well for violating the ‘Good Manufacturing Practices’ at their New Jersey plant. The letter sent by the FDA to Actavis categorically mentioned that it is difficult to ascertain whether the drugs are being manufactured using the right dosage.
It further mentions that the out-of-specification (OSS) test results were not documented properly and the product was released on the basis of retesting without providing any valid reasons for ignoring the initial OSS results.

In response to the FDA’s warning letter, Actavis responded by promising to take the corrective action. While Actavis seemed sensitive towards the issue, the FDA felt that it should have done more by taking a quick action and bringing in an external agency to ensure that it’s compliant with the good manufacturing practices.

Corrective measures
Pharmacies have been asked to check the list of their patients who have purchased Digitek and to personally inform them about the faulty medicine. The patients, who have consumed the medicine between March 2006 and April 2008, have been asked to consult their physicians and return the medicine to their suppliers.

For more information about the Digitek recall see Digitek Recall.